The following is a summary of the Teladoc Health, Inc. (TDOC) Q1 2024 Earnings Call Transcript:

Financial Performance:

• Teladoc reported Q1 revenue of $646 million, an increase of 3% year-over-year, surpassing their forecast.

• The Integrated Care segment reported an 8% YoY growth, with revenue of $377 million and a margin expansion to 12.6%.

• The BetterHelp segment saw a decline of 3.7%, reporting a revenue of $269 million.

• Adjusted EBITDA margin improved by 140 basis points YoY to 9.8%, with an adjusted EBITDA of $63 million growing nearly 20% year-over-year.

• Teladoc held over $1 billion in cash and cash equivalents at the end of the quarter.

Business Progress:

• Chronic Care enrolment increased 9% YoY in Q1.

• The US Integrated Care members grew by 8% over the prior year to $91.8 million, and the company expects to increase this number by the year-end further.

• The company increased its US Integrated Care membership outlook for the full year, following the addition of two million members in Q1.

• It expanded its services with a major health benefits provider, adding a diabetes program to the provider's offering.

• Teladoc is focusing on its international expansion, especially in English-speaking countries.

• The company remains committed to a Direct-to-Consumer (DTC) strategy for BetterHelp, aiming to reinforce its position in the DTC marketplace.

More details: Teladoc Health IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.